1.
COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports. Dermatol Reports [Internet]. 2023 Aug. 24 [cited 2025 Jun. 19];16(2). Available from: https://journals.pagepress.org/dr/article/view/9763